Related Experiment Video

Updated: Jul 28, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.1K

Nangibotide for precision immunomodulation in septic shock and COVID-19

Maniraj Neupane1, Sameer S Kadri1

  • 1Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD, USA; Critical Care Medicine Branch, National Heart Lung and Blood Institute, Bethesda, MD 20892, USA.

The Lancet. Respiratory Medicine
|June 3, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.6K
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

19.5K

Related Experiment Videos

Last Updated: Jul 28, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.1K
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.6K
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

19.5K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

402
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
402

Articles linked to this work by shared authors, journal, and citation graph.

NEWS2 versus shock status to stratify antibiotic urgency in patients with suspected sepsis: a retrospective, multicentre cohort study.

The Lancet. Respiratory medicine·2026

New and persistent psychoactive medication use in intensive care unit survivors with COVID-19: a multicentre population-based cohort study.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2026

Rapid Microbiological Diagnostics for Sepsis: Narrative Review of Current and Prospective Approaches.

Critical care explorations·2026

Impact of Procalcitonin Testing on Antibiotic Use in Patients Hospitalized With Community-Acquired Pneumonia: A Multi-Hospital Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Survival trends in patients with difficult-to-treat, antibiotic-resistant, Gram-negative infections in the era of next-generation antibiotics in the USA: a retrospective cohort study.

The Lancet. Infectious diseases·2026

National Estimates of Pediatric Sepsis in US Hospitals Using Clinical Data.

JAMA·2026

Cryobiopsy versus conventional bronchoscopic sampling for peripheral pulmonary lesions (Cryo-RCT): an open-label, parallel-group, randomised trial.

The Lancet. Respiratory medicine·2026

Global economic burden attributable to asthma, 2025-50: a global modelling analysis of 154 countries and territories.

The Lancet. Respiratory medicine·2026

FEF25-75% trajectories from age 7 to 53 years, associations with childhood and parental preconception factors, and midlife COPD risk: a prospective cohort study.

The Lancet. Respiratory medicine·2026

The role of sweat chloride in determining CFTR protein restoration in people with cystic fibrosis.

The Lancet. Respiratory medicine·2026

Reproductive health guidance for the cystic fibrosis community: a Cystic Fibrosis Foundation Position Paper.

The Lancet. Respiratory medicine·2026

Magneto-Fluorescent Mn-Doped CD@ZIF-8@Kappa Carrageenan Biohydrogel-A Dual Model Therapeutic and Diagnostic Agent for Targeted Drug Delivery and Cancer Therapy.

ACS applied bio materials·2026

Van der Knaap Disease Unveiled: A Radiological-Genomic Journey From Seizure to Diagnosis.

Cureus·2026

Incremental predictive value of CMR phenotyping for major adverse cardiovascular events: an interpretable machine learning study from UK Biobank.

Frontiers in medicine·2026

Sinonasal glomangiopericytoma presenting as refractory epistaxis: imaging, embolisation and pathological correlation.

BMJ case reports·2026

Integrating Confocal Laser Endomicroscopy and Label-Free Nanoplasmonic Biosensing for Intraoperative Glioblastoma Tissue Discrimination - A hypothesis generating study.

World neurosurgery·2026

Nose-to-Brain Nanocarriers for Migraine Management: A Comprehensive Review of Drug Delivery Strategies and Translational Challenges.

Current medical science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us